Harrow Health

Yahoo Finance • last year

Investigation Into Harrow, Inc. (HROW) Announced by Holzer & Holzer, LLC

ATLANTA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Harrow, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW) complied with federal securities laws. On November 13, 2023, Harrow released its third quart... Full story

Yahoo Finance • 2 years ago

Why Shares of Harrow Health Are Slumping Friday

Shares of Harrow Health (NASDAQ: HROW) were down more than 24% as of 1:45 p.m. ET Friday after the company reported first-quarter earnings following the close of trading Thursday. It set a quarterly record for revenue -- $26.1 million, up... Full story

Yahoo Finance • 2 years ago

Harrow Health, Inc.: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Harrow Health, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW) investo... Full story

Yahoo Finance • 2 years ago

Harrow Health Shareholder News: Johnson Fistel Encourages Harrow Health Shareholders with Losses to Contact the Firm Regarding Class Action Investigation

SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Harrow Health, Inc. ("Harrow Health" or the "Company") (NASDAQ: HROW), any of its executive officers, or others violate... Full story

Yahoo Finance • 2 years ago

Harrow Announces Permanent, Product-Specific J-Code (J2403) for IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia Effective April 1, 2023

NASHVILLE, Tenn., February 02, 2023--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a permanent, product-specific J-... Full story

Yahoo Finance • 3 years ago

Harrow Health Announces First Quarter 2022 Financial Results

Seventh Consecutive Quarter of Record Results Highlights for First Quarter 2022: Record revenues of $22.1 million, up 43% over $15.4 million for the prior-year quarter Record gross profit of $16.2 million, up 38% over $11.7 million for t... Full story